news

Indigo will be present during the J.P. Morgan 2020 Healthcare conference on January 13-16 in San Francisco, USA. If you are interested to talk to us, we will be delighted to meet you. Please contact us danae.delbeke@indigomed.com (+32 475 41 21 32)

Ghent, Belgium [November 22, 2019] – Indigo Diabetes NV, a medical device company creating next-gen sensors for diabetes healthcare, today announced it has received ISO 13485 certification from TÜV Süd for the Design and Development of Biomarker Sensing Devices and...

At Indigo we are working to improve the quality of life of millions of people with diabetes. Want to join our young dynamic team? We are hiring a Clinical Affairs Manager. Please visit our careers page for more information.

Indigo is pleased to announce that the first patient has now been enrolled into ‘Action-1”, the company’s prospective, non-randomized, interventional, multi-center data collection study. The study collects venous blood samples in male T1D patients to evaluate the...

We are extremely proud to announce the opening of our new lab in Ghent! We spent a couple of months building up a lab that provides all necessary equipment for our research and development. This is a huge improvement for our team. At Indigo we are committed to making...

We are extremely proud to announce the opening of our new lab in Ghent! We spent a couple of months building up a lab that provides all necessary equipment for our research and development. This is a huge improvement for our team. At Indigo we are committed to making...

Our CEO Danaë Delbeke in an interview for newspaper De Tijd (in Dutch).

Our DiaMOND Project on EASME. Personalised Diabetes Management using lOw-cost Needle-free multiple-biomarkers monitoring device.